Ultimately, whether microdosing becomes mainstream will depend on future clinical evidence
The authorized GLP-1 product portfolio is an innovative drug self-developed by Hengrui targeting diabetes, obesity, and other metabolic disorders
Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus
We have shown that liraglutide administration increases NE levels in plasma and cecal contents
22 Pharmacists can play a pivotal role in addressing these challenges by proactively discussing medication access with patients and tailoring solutions based on individual factors such as drug type, indication, insurance coverage, and personal circumstances
Axxams metabolic platform assays Enteroendocrine cells act as nutrient sensors in the gut, detecting dietary components through receptors located on their luminal surface